Dr. Stuart Akerman, MD

Dr. Akerman practices at Digestive Health Center of Plano in Plano, Texas.

Dr. Akerman's NPI, 1154652923, was assigned on January 19, 2010. Dr. Akerman graduated from Rutgers New Jersey Medical School in 2007. Dr. Akerman holds Texas license Q3843.

Dr. Akerman's primary practice is Digestive Health Center of Plano, at 3500 Preston Road Suite 200, Plano, TX 75093. The practice phone is (972) 985-2300.

Dr. Akerman's primary practice is Digestive Health Center of Plano in Plano, Texas. Dr. Akerman is also affiliated with Medical City Plano Hospital. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Akerman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akerman practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Akerman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Akerman is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Akerman's licenses on file in 2 states: Texas and New York.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Akerman treats.

CMS data shows 371 Medicare services from Dr. Akerman across 5 procedure codes in 2024, for 260 Medicare patients. Medicare paid $34,951 for them.

CMS counts 260 Medicare patients who saw Dr. Akerman in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Akerman's median patient age at 55, with 48% women.

In 2024, Dr. Akerman wrote 825 Medicare Part D claims for 268 patients. 80% of them were for generic drugs. CMS names the drug for 662 of them, across 12 drugs with 11 or more claims each, at $360,843 in total drug cost. In 2023, CMS named 668 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Akerman for performance year 2024, reported as part of a group. Dr. Akerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 140 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Akerman, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Akerman, published from 2012 to 2014. 2014 was the busiest year, with 2. The most frequent topics are Endoscopes, Equipment Design and New York. Dr. Akerman has published most often in Eur J Gastroenterol Hepatol. Dr. Akerman's most frequent co-authors are Merajur Rahman, MD, Keith S. Sultan, MD and David Bernstein, MD.

CMS Open Payments shows 419 general payments to Dr. Akerman from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 85% of the total. Aimmune Therapeutics, Inc. paid the most, $94,287.

Dmand AI lists 1 award for Dr. Akerman, most recently CMS Stage 1 EHR in 2013.

Dr. Akerman graduated from Rutgers New Jersey Medical School in 2007. Dr. Akerman is a member of ACG, AGA and ASGE.

Dr. Akerman is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.